NeuroOne gains FDA clearance for trigeminal nerve ablation
The minimally invasive system uses radiofrequency energy to target nerve tissue causing facial pain.
NeuroOne gains FDA clearance for trigeminal nerve ablation Read More »
The minimally invasive system uses radiofrequency energy to target nerve tissue causing facial pain.
NeuroOne gains FDA clearance for trigeminal nerve ablation Read More »
Aktiia received FDA clearance in July for the first cuffless blood pressure monitor authorized to be sold over the counter.
How Aktiia built the first over-the-counter cuffless blood pressure monitor Read More »
Reed O’Connor’s ruling is a setback for smaller MA plans — and efforts to curb predatory marketing to seniors.
Judge overturns rule limiting broker payments in Medicare Advantage Read More »
The startup intends to make a small patch pump with a closed-loop algorithm for nighttime glucose control.
Luna Health raises $23.6M for tiny insulin patch pump Read More »
Overall customer satisfaction with MA plans fell 29 points year over year, driven by a declining level of member trust in their health plans, according to J.D. Power.
Medicare Advantage headwinds dinging member satisfaction: survey Read More »
In late May, a patient died after receiving Rocket Pharmaceuticals’ investigational gene therapy for Danon disease, spurring the hold. After lowering the dose and changing the regimen of immune modulators patients receive, the company has received FDA clearance for the trial to continue.
Rocket Re-Ignites Phase II Trial After FDA Lifts Clinical Hold Read More »
The Texas judge’s decision — which picked apart Elevance’s argument on mathematical grounds — could cost Elevance $375 million, though the insurer could still appeal.
Elevance loses Medicare Advantage star ratings suit Read More »
The CDC no longer recommends COVID-19 vaccines for healthy children and healthy pregnant women, a position that has been opposed by leading medical societies.
American Academy of Pediatrics Contradicts CDC, Recommends COVID-19 Shot for Kids Read More »
Regulations aiming to lower the cost of vital medicines will instead end up restricting access and disincentivizing R&D.
Look to Competition, Not Mandates, to Lower Drug Prices Read More »
With its structural changes, CSL expects to generate $500 to $550 million in annualized savings over the next three years.
CSL Overhauls Business With Vaccine Spinout, 15% Layoffs Read More »